HGF and cardiovascular disorder: Hepatocyte growth factor (HGF) and its receptor Mesenchymal-epithelial transition factor (Met), which was originally found to be a potent mitogen that promotes hepatocyte growth and liver regeneration [5, 6], are now proposed to have prominent roles in the cardiovascular diseases.